drugset / Trial / NCT01951651

Effect of Exenatide on Liver and Heart Fat and Inflammation

NCT01951651

Phase 4 Completed 24 enrolled Baylor College of Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the effect of exenatide on liver and heart (myocardial) fat and inflammation.

Timeline

Start
2010-04
Primary completion
2012-10
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Exenatide Peptide 10 ug Subcutaneous
Subject Glipizide Small molecule 5 mg Oral